Exciting updates from ASCO GI 2021

Vivek Subbiah, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, explores upcoming trial updates to be presented at this years American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, including the use of FGFR inhibitors in cholangiocarcinoma, as well as using circulating DNA in the management of gastrointestinal malignancies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).